$CGNX

COGNEX CORP

AlphAI earnings readSecond quarter 2026 · AUG 5 · NEXT NOV 4Cognex Reports Second Quarter 2026 ResultsVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
0
1

No SEC Form 4 filings for $CGNX in the last 30 days.

See all $CGNX insider activity →

Cognex, Insight Enterprises, and SAIC Stocks Trade Down, What You Need To Know

Cognex (CGNX), Insight Enterprises (NSIT), and SAIC (SAIC) fell 4%, 3.8%, and 2.8% respectively, as September inflation rose to 3.7%, surpassing expectations and driving bond yields higher. Elevated inflation and interest rates may compress valuations, particularly in growth sectors like technology. Cognex's volatility continues, with shares down 20.5% from their 52-week high. Truist lowered its price target for Cognex to $74, maintaining a Hold rating.

CGNX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning CGNX (COGNEX CORP). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent CGNX coverage spans financial news, earnings and market movers.

What's driving CGNX

AlphAI scores every news story that mentions CGNX with an AI model for sentiment and relevance, and aggregates insider trades from COGNEX CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CGNX

Score

Cognex, Insight Enterprises, and SAIC Stocks Trade Down, What You Need To Know

Cognex (CGNX), Insight Enterprises (NSIT), and SAIC (SAIC) fell 4%, 3.8%, and 2.8% respectively, as September inflation rose to 3.7%, surpassing expectations and driving bond yields higher. Elevated inflation and interest rates may compress valuations, particularly in growth sectors like technology. Cognex's volatility continues, with shares down 20.5% from their 52-week high. Truist lowered its price target for Cognex to $74, maintaining a Hold rating.

$CGNXMed

CGNX Maintained by Barclays -- Price Target Raised to $85.00

Barclays maintained an Overweight rating on Cognex (CGNX) and raised its price target to $85.00 from $80.00. The company's GF Value™ suggests it is 15.6% overvalued, while its GF Score™ is 86/100. Cognex is a leading manufacturer of machine vision systems, with a market cap of $10.38 billion. Insider activity shows mixed sentiment, with some gurus adding positions while others trimmed.

Why Cognex (CGNX) Stock Is Falling Today

Cognex (CGNX) shares fell 7.5% due to rising Treasury yields, oil prices, and a Truist price target cut to $74. The company's stock is volatile, up 67.5% YTD but down 14.6% from its 52-week high. Truist expects constructive company commentary despite near-term challenges.

Will Wafer ID Launch Change Cognex's (CGNX) Narrative

Cognex launched the In-Sight 1750 Series, a wafer and panel identification system for semiconductor production, designed as a drop-in upgrade from the In-Sight 1740. Analysts expect Cognex to reach $1.5B in revenue and $386.7M in earnings by 2029, with a 10.3% yearly revenue growth rate. The launch supports Cognex's AI-driven vision narrative but does not change near-term focus on scaling OneVision and newer verticals.

$CGNXMed

Industry Insights: RealSense's CEO on Intel, Cognex, and Momentary Startup Status

RealSense's CMO Mike Nielsen discussed the company's journey post-spinoff from Intel, its fundraising efforts, and recent acquisition by Cognex. Nielsen highlighted RealSense's growth, supply chain challenges, and the strategic fit with Cognex. The company's technology, including depth sensing, remains central to its offerings, with a focus on developer engagement and humanoid robotics.

Related tickers